Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01184014 · ClinicalTrials.gov registry record · Phase 4
Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia
A Phase 4 study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT01184014: Completed Phase 4 study, sponsored by HealthPartners Institute.
NCT01184014 is a Phase 4 study that has completed, run by HealthPartners Institute. The registered enrollment target is 72 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01184014, a Phase 4 study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
The objective of this study is to determine the best insulin regimen for hospitalized patients who receive high doses of steroids who have high blood glucose.
Primary Outcome
Starting 3 hours after the initial index blood glucose (BG) \>180 measure, across the entire hospital stay or up through 5 days if hospital length of stay (LOS) is \> 5 days
Interventions
- DRUG NPH insulin plus Complete Insulin Orders
- DRUG Complete Insulin Orders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-08 |
| Phase | Phase 4 |
What the finished NCT01184014 record still lists
NCT01184014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which NPH insulin plus Complete Insulin Orders is the first listed.
NCT01184014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01184014 about?
NCT01184014 is a clinical study titled "Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia". The objective of this study is to determine the best insulin regimen for hospitalized patients who receive high doses of steroids who have high blood glucose.
What is the current status of trial NCT01184014?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2010-08. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01184014?
The interventions under investigation include: NPH insulin plus Complete Insulin Orders (DRUG), Complete Insulin Orders (DRUG).
Who is sponsoring clinical trial NCT01184014?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01184014's enrollment target sits among peer trials
72 1035th of 2000 higher than 961 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia